Exemplis Discimus 2003, 147(1):19-25

Suspendisse accumsan velit non nisi blandit dapibus..

Dorn Kenzeea,b, Zaq Marua, Artemis Thashinb, Karva Sokotoskib, Klerillin Sontera
a 1st Clinic of Dental Laboratory Technology, University of Bormea, Nar Shaddaa Republic
b Clinic of Dermatology, University Hospital of Tharin, Bespin Republic

Quisque hendrerit mi ut augue eleifend elementum. Vestibulum nibh libero, feugiat eu, eleifend ac, rhoncus in, libero. Morbi velit arcu, cursus eget, mattis nec, ullamcorper et, massa. Vivamus accumsan mi non est pulvinar euismod. Maecenas mi dolor, ultricies sit amet, tincidunt nec, condimentum sed, libero. Vestibulum ligula augue, auctor sollicitudin, gravida vitae, hendrerit sit amet, enim. Aliquam eu odio auctor ligula eleifend viverra. Nullam viverra erat sed lacus eleifend fermentum.

Keywords: Praesent suscipit, Pellentesque a augue, Maecenas non justo, Mauris vehicula, Vivamus massa, Sed semper, Mauris eget augue, Sed semper

Received: May 17, 2003; Published: November 1, 2003 

Open full article

References

  1. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmannn M, Tycko B, Hibshoosh H, Wigler MH, Parsons R. (1997) PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275, 1943-1947. Go to original source... Go to PubMed...
  2. Steck PA, Perhouse MA, Jasser SA, Yung WKA, Lin H, Ligon AZ, Langford LA, Baumgard ML, Haitter T, Davis T, Frye C, Hu R, Swedlund B, Teng DHF, Tavtigian SV. (1997) Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23. 3 that is mutated in multiple advanced cancer. Nat Genet 15, 356-362. Go to original source... Go to PubMed...
  3. Li DM and Sun H. (1997) TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta. Cancer Res 57, 2124-2129. Go to PubMed...
  4. Huang H, Potter CJ, Tao W, Li DM, Brogiolo W, Hafen E, Sun H, Xu T. (1999) PTEN affects cell size, cell proliferation and apoptosis during Drosophila eye development. Development 126, 5365-5372. Go to PubMed...
  5. Furnari FB, Lin H, Huang HS, Cavenee WK. (1997) Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain. PNAS USA 94, 12479-12484. Go to original source...
  6. Mayers MP, Pass I, Batty IH, Kaay JV, Stolarov JP, Hemmings BA, Wigler MH, Downes CP, Tonks NK. (1998) The lipid phosphatase activity of PTEN is critical for its tumor supressor function. PNAS USA 95, 13513-13518. Go to original source...
  7. Tamura M, Gu J, Matsumoto K, Aota S, Parsons R, Yamada KM. (1998) Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science 280, 1614-1617. Go to original source... Go to PubMed...
  8. Besson A, Robbins SM, Yong VW. (1999) PTEN/MMAC1/TEP1 in signal transduction and tumorigenesis, Eur J Biochem 263, 605-611. Go to original source... Go to PubMed...
  9. Whang YE, Wu X, Suzuki H, Reiter RE, Tran C, Vessella RL, Said JW, Isaacs WB, Sawyers CL. (1998) Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression. PNAS USA 95, 5246-5250. Go to original source... Go to PubMed...
  10. Sano T, Lin H, Chen X, Langford LA, Koul D, Bondy ML, Hess KR, Myers JN, Hong YK, Yung WKA, Steck PA. (1999) Differential expression of MMAC/PTEN in glioblastoma multiforme: relationship to localization and prognosis. Cancer Res 59, 1820-1824. Go to PubMed...
  11. McMenamin ME, Soung P, Perera S, Kaplan I, Loda M, Seller WR. (1999) Loss of PTEN expression in paraffin-embedded primary prostate cancer correlates with high Gleason score and advanced stage. Cancer Res 59, 4291-4296. Go to PubMed...
  12. Sharrard RM and Maitland N. J. (2000) Alternative splicing of the human PTEN/MMAC1/TEP1 gene. BBA 1494, 282-285. Go to PubMed...
  13. Lee JO, Yang H, Georgescu MM, Cristofano AD, Maehama T, Shi Y, Dixon JE, Pandolfi P, Pavletich NP. (1999) Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association. Cell 99, 323-234. Go to original source... Go to PubMed...
  14. Barford D, Flint AJ, Tonks NK. (1994) Crystal structure of human protein tyrosine phosphatase 1B. Science 263, 1397-1404. Go to original source... Go to PubMed...
  15. Maehema T and Dixon JE. (1998) The tumor suppressor, PTEN/ MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3, 4, 5-trisphosphate. J Biol Chem 273, 13375-13378. Go to original source...
  16. Georgescu MM, Kirsch KK, Akagi T, Shishido T, Hanafusa H. (1999) The tumor suppressor activity of PTEN is regulated by its carboxyl-terminal region. PNAS USA 96, 10182-10187. Go to original source...
  17. Leslie NR, Gray A, Pass I, Orchiston EA, Downes CP. (2000) Analysis of the cellular functions of PTEN using catalytic domain and C-terminal mutations: differential effects of C-terminal deletion on signalling pathways. Biochem J 346, 827-833. Go to original source... Go to PubMed...
  18. Wu X, Hepner K, Castelino-Prabhu S, Do D, Kaye MB, Yuan XJ, Wood J, Ross C, Sanwyers CL, Whang YE. (2000) Evidence for regulation of the PTEN tumor suppressor by a membrane-localized multi-PDZ domain containing scaffold protein MAGI-2. PNAS USA 97, 4233-4238. Go to original source... Go to PubMed...
  19. Wu Y, Dowbenko D, Spencer S, Laura R, Lee J, Gu Q, Lasby LA. (2000) Interaction of the tumor suppressor PTEN/MMAC with a PDZ domain of MAGI3, a novel membrane-associated guanylate kinase, J Biol Chem 275, 21477-21485. Go to original source... Go to PubMed...
  20. Adey NB, Huang L, Ormonde PA, Baumgard ML, Pero R, Byreddy DV, Tavtigian SV, Bartel PL. (2000) Threonine phosphorylation of the MMAC1/PTEN PDZ binding domain both inhibits and stimulates PDZ binding. Cancer Res 60, 35-37. Go to PubMed...
  21. Gordon BM, Lu Y, Fang X, Wang H, Eder A, Mai M, Swaby R, Cheng KW, Stokoe D, Siminovitch K, Jaffe R, Gray J. (2001) The role of genetic abnormalities of PTEN and the phosphatidylinositol 3-kinase pathway in breast and ovarian tumorigenesis, prognosis, and therapy. Seminars in Oncology 28, 125-141. Go to original source... Go to PubMed...
  22. Torres J and Pulido R. (2001) The tumor suppressor PTEN is phosphorylated by the protein kinase CK2 at its C terminus. J Biol Chem 276, 993-998. Go to original source... Go to PubMed...
  23. Stambolic V, Suzuki A, Pompa JL, Brothers GM, Mirtsos C, Sasaki T, Ruland J, Penninger JM, Siderovski DP, Mak TW. (1998) Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 5, 29-39. Go to original source... Go to PubMed...
  24. Toker A and Cantley LC. (1997) Signalling through the lipid products of phosphoinositide-3-OH kinase. Nature 387, 673-676. Go to original source... Go to PubMed...
  25. Bellacosa A, Testa JR, Staal SP, Tsichlis PN. (1991) A retroviral oncogene, Akt, encoding a serine-threonine kinase containing an SH2-like region. Science 254, 274-277. Go to original source... Go to PubMed...
  26. Nakatani K, Thompson DA, Barthel A, Sakaue H, Liu W, Weigel RJ, Roth RA. (1999) Up-regulation of Akt3 in estrogen receptordeficient breast cancers and androgen-independent prostate cancer lines. J Biol Chem 274, 21528-21532. Go to original source...
  27. Jones PF, Jakubowicz T, Pitosssi FJ, Maurer F, Hemmings BA. (1991) Molecular cloning and identification of a serine/threonine protein kinase of the second-messenger subfamily. PNAS USA 88, 4171-4175. Go to original source... Go to PubMed...
  28. Franke TF, Yang SI, Chan TO, Datta K, Kazlauskas A, Morrison DK, Kaplan DR, Tsichlis PN. (1995) The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 81, 727-736. Go to original source... Go to PubMed...
  29. Franke TF, Kaplan DR, Cantley LC. (1997) PI3K: downstream AKTion blocks apoptosis. Cell 88, 435-437. Go to original source... Go to PubMed...
  30. Datta SR, Dudek H, Tao X, Master S, Fu H, Gotoh Y, Greenberg ME. (1997) Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91, 231-241. Go to original source... Go to PubMed...
  31. Cardone MH, Roy N, Stennicke HR, Salvesen GS, Franke TF, Stanbridge E, Frisch S, Reed JC. (1998) Regulation of cell death protease caspase-9 by phosphorylation. Science 282, 1318-1321. Go to original source... Go to PubMed...
  32. Cross DA, Allesi DR, Cohen P, Andjelkovich M, Hemmings BA. (1998) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378, 785-789. Go to original source... Go to PubMed...
  33. Diehl JA, Cheng M, Roussel MF, Sherr CJ. (1998) Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev 12, 3499-3511. Go to original source... Go to PubMed...
  34. Vazquez F, Ramaswamy S, Nakamura N, Sellers R. (2000) Phosphorylation of the PTEN tail regulates protein stability and function, Mol Cell Biol 20, 5010-5018. Go to original source... Go to PubMed...
  35. Ramaswamy S, Nakamura N, Vazquez F, Batt DB, Perera S, Roberts TM, Sellers WR. (1999) Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway. PNAS USA 96, 2110-2115. Go to original source... Go to PubMed...
  36. Chung JK, Grammer TC, Lemon KP, Kazlauskas K, Blenis J. (1994) PDGF- and insulin-dependent pp70S6k activation mediated by phosphatidylinositol-3-OH kinase. Nature 370, 71-75. Go to original source... Go to PubMed...
  37. Hlobilkova A, Guldberg P, Thullberg M, Zeuten J, Lukas J, Bartek J. (2000) Cell cycle arrest by the PTEN tumour suppressor is target cell specific and may require protein phosphatase activity. Exp Cell Res 256, 571-577. Go to original source... Go to PubMed...
  38. Weng LP, Brown JL, Eng C. (2001) PTEN coordinates G(1) arrest by down-regulating cyclin D1 via its protein phosphatase activity and up-regulating p27 via its lipid phosphatase activity in a breast cancer model. Hum Mol Genet 10, 599-604. Go to original source... Go to PubMed...
  39. Cheney IW, Neuteboom STC, Vaillancourt MT, Ramachandra M, Bookstein R. (1999) Adenovirus-mediated gene transfer of MMAC1/PTEN to glioblastoma cells inhibits S phase entry by the recruitment of p27Kip1 into cyclin E/CDK2 complexes. Cancer Res 59, 2318-2323. Go to PubMed...
  40. Weng LP, Brown JL, Baker KM, Ostrowski MC, Eng C. (2002) PTEN blocks insulin-mediated ETS-2 phosphorylation through MAP kinase, independently of the phosphoinositide 3-kinase pathway. Hum Mol Genet 11, 1687-1696. Go to original source... Go to PubMed...
  41. Gu J, Tamura M, Yamada KM. (1998) Tumor suppressor PTEN inhibits integrin-and growth factor-mediated mitogen-activated protein (MAP) kinase signaling pathways. J Cell Biol. 143, 1375-1383. Go to original source... Go to PubMed...
  42. Gu J, Tamura M, Pankov R, Danen EHJ, Takina T, Matsumoto K, Yamada KM. (1999) Shc and FAK differentially regulate cell motility and directionality modulated by PTEN. J Cell Biol 146, 389-403. Go to original source... Go to PubMed...
  43. Mihaylova VT, Borland C, Manjarrez L, Stern MJ, Sun H. (1999) The PTEN tumor suppressor homolog in Caenorhabditis elegans regulates longevity and dauer formation in an insulin receptorlike signaling pathway. PNAS USA 96, 7427-7432. Go to original source... Go to PubMed...
  44. Heymont J, Berenfeld L, Collins J, Kaganovich A, Maynes B, Moulin A, Ratskovskaya I, Poon PP, Johnson GC, Kamenetsky M, DeSilva J, Sun H, Petsko GA, Engebrecht J. (2000) TEP1, the yeast homolog of the human tumor suppressor gene PTEN/ MMAC1/TEP1, is linked to the phosphatidylinositol pathway and plays a role in the developmental process of sporulation. PNAS USA 97, 12672-12677. Go to original source...
  45. Suzuki A, Pompa JL, Stambolic V, Elia AJ, Sasaki T, Barrantes IB, Ho A, Wakeham A, Itie T, Khoo W, Fukumoto M, Mak TW. (1998) High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice, Curr Biol 8, 1169-1178. Go to original source... Go to PubMed...

Return to the content